68Ga-PSMA PET/CT in early relapsed prostate cancer patients after radical therapy
Abstract Biochemical recurrence (BCR) of prostate cancer (PCa) occurs in about 25% of patients treated with radical prostatectomy (RP) and up to 45% in patients who receive external beam radiotherapy (RT). Early diagnosis of PCa recurrence is of high importance for successful salvage therapy. The ai...
Main Authors: | Mohamad Haidar, Alain S. Abi-Ghanem, Hicham Moukaddam, Malak El Jebai, Safaa Al Zakleet, Samir Al Rayess, Abdul Rahman Akkawi, Mutaz Kassas, Hani Tamim, Albert El Hajj, Enrique Estrada-Lobato, Medhat M. Osman, Ali Shamseddine |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-11-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-24688-3 |
Similar Items
-
The Clinical Significance of Incidental GIT Uptake on PET/CT: Radiologic, Endoscopic, and Pathologic Correlation
by: Mohammad N. Hosni, et al.
Published: (2023-03-01) -
Prone versus Supine FDG PET/CT in the Staging of Breast Cancer
by: Lara Nassar, et al.
Published: (2023-01-01) -
Application of 68Ga-PSMA-11 and 18F-PSMA-1007 in prostate cancer
by: Hu Siqi, Zhang Yong
Published: (2022-01-01) -
PSMA as a Theranostic Target in Hepatocellular Carcinoma: Immunohistochemistry and 68Ga‐PSMA‐11 PET Using Cyclotron‐Produced 68Ga
by: Scott M. Thompson, et al.
Published: (2022-05-01) -
Comparison of PSMA-TO-1 and PSMA-617 labeled with gallium-68, lutetium-177 and actinium-225
by: Catherine Meyer, et al.
Published: (2022-10-01)